Aldeyra Therapeutics, Inc. (ALDX) › Capital ExpendituresAldeyra Therapeutics, Inc. (ALDX) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2014: $14.1K2015: $86.1K2016: $11.8K2017: $24.8K2018: $263.0K2019: $9.5K2021: $7.8K2022: $16.3K2023: $0$02014Capital Expenditures (USD)2023Fiscal YearCapital ExpendituresChange YoY2023$0-100.0%2022$16.3K+109.0%2021$7.8K—2019$9.5K-96.4%2018$263.0K+962.1%2017$24.8K+109.6%2016$11.8K-86.3%2015$86.1K+512.4%2014$14.1K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share